Concord Wealth Partners’s CONMED CNMD Stock Holding History

Concord Wealth Partners’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-21	Closed	-$3K	–	1255
2022 Q1	$3K	Hold	21	–	–	﹤0.01%	1001
2021 Q4	$3K	Buy	+21	New	+$2.97K	﹤0.01%	1036
2021 Q3	–	Sell	-12	Closed	-$2K	–	931
2021 Q2	$2K	Sell	12 -17	-59%	-$2.33K	﹤0.01%	875
2021 Q1	$4K	Buy	29 +11	+61%	+$1.32K	﹤0.01%	702
2020 Q4	$2K	Buy	+18	New	+$1.7K	﹤0.01%	522

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Concord Wealth Partners's CNMD Position: Q2 2022 in Review

Concord Wealth Partners sold out of CONMED (CNMD) in Q2 2022, closing a stake of 21 shares — an estimated $3K sold.

Concord Wealth Partners first reported a position in CNMD in Q4 2020 and held it in 5 quarters. The position peaked at $4K in Q1 2021. 280 funds tracked by Wall St. Rank hold CNMD as of Q2 2022.

Concord Wealth Partners reported no remaining CONMED position as of Q2 2022 after selling out during the quarter.
Concord Wealth Partners sold 21 CONMED shares in Q2 2022, an estimated $3K.
Concord Wealth Partners first reported a position in CONMED in Q4 2020 and held it in 5 quarters.
Concord Wealth Partners's CONMED position peaked at $4K in Q1 2021.
280 funds tracked by Wall St. Rank held CONMED as of Q2 2022.

Based on Concord Wealth Partners's 13F filing for Q2 2022, filed 4 Aug 2022.